Shaikh F, Wynne R, Castelino R, Davidson P, Inglis S, Ferguson C
Clin Cardiol. 2024; 47(8):e24336.
PMID: 39169682
PMC: 11339320.
DOI: 10.1002/clc.24336.
Sha R, Baines O, Hayes A, Tompkins K, Kalla M, Holmes A
J Am Heart Assoc. 2023; 13(1):e032277.
PMID: 38156451
PMC: 10863823.
DOI: 10.1161/JAHA.123.032277.
Kvitne K, Hovd M, Johnson L, Wegler C, Karlsson C, Artursson P
Clin Pharmacokinet. 2023; 63(1):109-120.
PMID: 37993699
PMC: 10786955.
DOI: 10.1007/s40262-023-01320-9.
Morse J, Cortinez L, Anderson B
J Clin Med. 2023; 12(4).
PMID: 36836174
PMC: 9960599.
DOI: 10.3390/jcm12041642.
Aronson J, Grahame-Smith D
Br J Clin Pharmacol. 2012; 3(4):639-48.
PMID: 22216507
PMC: 1428900.
DOI: 10.1111/j.1365-2125.1976.tb04888.x.
The appropriate use of serum digoxin assay.
Dodek A
Can Fam Physician. 2011; 23:107-13.
PMID: 21304851
PMC: 2378778.
Therapeutic drug monitoring of antiarrhythmic drugs.
Jurgens G, Graudal N, Kampmann J
Clin Pharmacokinet. 2003; 42(7):647-63.
PMID: 12844326
DOI: 10.2165/00003088-200342070-00004.
Frank I. Marcus.
HURST J
Clin Cardiol. 1998; 21(6):452-4.
PMID: 9631279
PMC: 6655394.
DOI: 10.1002/clc.4960210618.
Pharmacokinetics of drugs in obesity.
Abernethy D, Greenblatt D
Clin Pharmacokinet. 1982; 7(2):108-24.
PMID: 7039924
DOI: 10.2165/00003088-198207020-00002.
A standard approach to compiling clinical pharmacokinetic data.
Sheiner L, Benet L, Pagliaro L
J Pharmacokinet Biopharm. 1981; 9(1):59-127.
PMID: 7014827
DOI: 10.1007/BF01059343.
Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients.
Bauer L, Edwards W, Dellinger E, Simonowitz D
Eur J Clin Pharmacol. 1983; 24(5):643-7.
PMID: 6873144
DOI: 10.1007/BF00542215.
Pharmacokinetics of digoxin in pregnancy.
Luxford A, Kellaway G
Eur J Clin Pharmacol. 1983; 25(1):117-21.
PMID: 6617713
DOI: 10.1007/BF00544027.
Antiarrhythmic agents. II. Therapeutic considerations.
Mason D, DeMaria A, Amsterdam E, Zelis R, MASSUMI R
Drugs. 1973; 5(4):292-317.
PMID: 4724237
DOI: 10.2165/00003495-197305040-00003.
Clinical pharmacology and therapeutics use of digitalis glycosides.
Doherty J, KANE J
Drugs. 1973; 6(3):182-221.
PMID: 4273255
DOI: 10.2165/00003495-197306030-00005.
Drug disposition in obese humans. An update.
Abernethy D, Greenblatt D
Clin Pharmacokinet. 1986; 11(3):199-213.
PMID: 3524955
DOI: 10.2165/00003088-198611030-00002.
Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.
OConnor P, Feely J
Clin Pharmacokinet. 1987; 13(6):345-64.
PMID: 3325214
DOI: 10.2165/00003088-198713060-00001.
Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations.
Mooradian A
Clin Pharmacokinet. 1988; 15(3):165-79.
PMID: 3052985
DOI: 10.2165/00003088-198815030-00002.
Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.
Koup J, Greenblatt D, Jusko W, Smith T, Koch-Weser J
J Pharmacokinet Biopharm. 1975; 3(3):181-92.
PMID: 1159622
DOI: 10.1007/BF01067907.
Bioavailability and pharmacokinetics of beta-methyldigoxin after multiple oral and intravenous doses.
Rietbrock N, Guggenmos J, Kuhlmann J, Hess U
Eur J Clin Pharmacol. 1976; 09(5-6):373-9.
PMID: 971702
DOI: 10.1007/BF00606551.
Digoxin measurements in general practice.
Holt D, Williamson J, Volans G
Br J Clin Pharmacol. 1977; 4(3):321-6.
PMID: 901700
PMC: 1429082.
DOI: 10.1111/j.1365-2125.1977.tb00720.x.
